Gaps In Supplement AER Guidance Speak Volumes
This article was originally published in The Tan Sheet
Executive Summary
FDA's draft guidance for dietary supplement adverse event reports did not receive an Office of Management and Budget review, and the agency avoided a significant delay to its publication by not recommending substantial changes to product labels, industry experts observe